Rodman and Renshaw


Rodman and Renshaw Sings the Praises of Capricor Therapeutics, Inc. (CAPR); Here’s Why

On Tuesday, Capricor Therapeutics, Inc. (NASDAQ:CAPR) was granted FDA Rare Pediatric Disease Designation for CAP-1002, the company’s treatment for Duchenne muscular dystrophy (DMD) and …

Sophiris Bio Inc (SPHS): Phase 2b Trial One Step a Way to Take Off

Drug maker Sophiris Bio Inc (NASDAQ:SPHS) released its earnings report for the first quarter of 2017 and is one step closer to beginning Phase …

Healthcare Analysts Change Price Targets on Valeant Pharmaceuticals Intl Inc (VRX) and Depomed Inc (DEPO) Following Recent Events

Healthcare analysts expressed their opinions on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Depomed Inc (NASDAQ:DEPO) following a credit facility waiver and a battle …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts